-
Elham Sajjadi，Konstantinos Venetis，Mariia Ivanova，Nicola Fusco（Division of Pathology；Department of Oncology and Hemato-Oncology）.Improving HER2 testing reproducibility in HER2-low breast cancer[J].癌症耐药(英文),2022,第4期
-
Danilo Rocco，Luigi Della Gravara，Giovanni Palazzolo，Cesare Gridelli（Department of Pulmonary Oncology；Department of Experimental Medicine；UO Oncologia；Division of Medical Oncology）.The role of antiangiogenic monoclonal antibodies combined to EGFR-TKIs in the treatment of advanced non-small cell lung cancer with activating EGFR mutations：acquired resistance mechanisms and strategies to overcome them[J].癌症耐药(英文),2022,第4期
-
Stefania Morganti，Mariia Ivanova，Emanuela Ferraro，Liliana Ascione，Grazia Vivanet，Giuseppina Bonizzi，Giuseppe Curigliano，Nicola Fusco，Carmen Criscitiello（Division of Early Drug Development for Innovative Therapies；Department of Oncology and Haemato-Oncology；Breast Oncology Center；Biobank for Translational and Digital Medicine Unit；Division of Pathology；Breast Medicine Service）.Loss of HER2 in breast cancer：biological mechanisms and technical pitfalls[J].癌症耐药(英文),2022,第4期
-
Lisa D.Eli，Shyam M.Kavuri（Translational Medicine and Diagnostics；Lester and Sue Smith Breast Center；Department of Medicine）.Mechanisms of neratinib resistance in HER2-mutant metastatic breast cancer[J].癌症耐药(英文),2022,第4期
-
Ahmad R.Safa（Department of Pharmacology and Toxicology）.Drug and apoptosis resistance in cancer stem cells：a puzzle with many pieces[J].癌症耐药(英文),2022,第4期
-
Wenyu Wang，Bing Cheng，Qiang Yu（Guangdong Provincial Key laboratory of Colorectal and Pelvic Floor Disease；Guangdong Research Institute of Gastroenterology；Cancer Precision Medicine；Department of Physiology；Cancer and Stem Cell Biology）.Cancer-associated fibroblasts as accomplices to confer therapeutic resistance in cancer[J].癌症耐药(英文),2022,第4期
-
Fatih M.Uckun，Sanjive Qazi（Ares Pharmaceuticals）.Tyrosine kinases in KMT2A/MLL-rearranged acute leukemias as potential therapeutic targets to overcome cancer drug resistance[J].癌症耐药(英文),2022,第4期
-
Leroy Lowe，J.William LaValley，Dean W.Felsher（Getting to Know Cancer（NGO）；Wellness Plan MD Ltd；Division of Oncology）.Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach[J].癌症耐药(英文),2022,第4期
-
scar Zuniga，Stephanie Byrum，Adam R.Wolfe（Department of Radiation Oncology；Department of Biochemistry and Molecular Biology）.Discovery of the inhibitor of DNA binding 1 as a novel marker for radioresistance in pancreatic cancer using genome-wide RNA-seq[J].癌症耐药(英文),2022,第4期
-
Maria D’Amico，Francesca De Amicis（Department of Pharmacy；Health Center）.Aberrant Notch signaling in gliomas：a potential landscape of actionable converging targets for combination approach in therapies resistance[J].癌症耐药(英文),2022,第4期
-
Huafeng Wang，Shi Li，Yiting Yang，Lei Zhang，Yinghao Zhang，Tianxiang Wei（School of Environment；School of Chemistry and Materials Science）.Perspectives of metal-organic framework nanosystem to overcome tumor drug resistance[J].癌症耐药(英文),2022,第4期
-
Gourab Gupta，George Merhej，Shakthika Saravanan，Hexin Chen（Department of Biological Science）.Cancer resistance to immunotherapy：What is the role of cancer stem cells?[J].癌症耐药(英文),2022,第4期
-
Daniela Furrer，Dzevka Dragic，Sue-Ling Chang，Frédéric Fournier，Arnaud Droit，Simon Jacob，Caroline Diorio（Centre de Recherche sur le cancer de l’UniversitéLaval；Axe Oncologie；Département de médecine sociale et préventive；UniversitéParis-Saclay；Département de médecine moléculaire；Département de biologie moléculaire；Centre des Maladies du Sein）.Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2- positive breast cancer patients：new findings and a systematic review[J].癌症耐药(英文),2022,第4期
-
Argia Ucci，Nadia Rucci，Marco Ponzetti（Department of Biotechnological and Applied Clinical Sciences）.Liquid biopsies in primary and secondary bone cancers[J].癌症耐药(英文),2022,第3期
-
Alex J.Eustace，Min Jie Lee，Grace Colley，Jack Roban，Tim Downing，Paul J.Buchanan（DCU Cancer Research；National Institute Cellular Biotechnology；School of Biotechnology；School of Nursing）.Aberrant calcium signalling downstream of mutations in TP53 and the PI3K/AKT pathway genes promotes disease progression and therapy resistance in triple negative breast cancer[J].癌症耐药(英文),2022,第3期
-
Ashish Kumar，Pawan Kumar，Mitu Sharma，Susy Kim，Sangeeta Singh，Steven J.Kridel，Gagan Deep（Department of Cancer Biology；Division of Pathology；Wake Forest Baptist Comprehensive Cancer Center）.Role of extracellular vesicles secretion in paclitaxel resistance of prostate cancer cells[J].癌症耐药(英文),2022,第3期
-
Matias Tellado，Sebastian Michinski，Joseph Impellizeri，Guillermo Marshall，Emanuela Signori，Felipe Maglietti（VetOncologia；Instituto de Fisica del Plasma；Veterinary Oncology Services；Laboratory of Molecular Pathology and Experimental Oncology；Instituto Universitario del Hospital Italiano-CONICET）.Electrochemotherapy using thin-needle electrode improves recovery in feline nasal planum squamous cell carcinoma-a translational model[J].癌症耐药(英文),2022,第3期
-
Kenneth K.W.To，William C.S.Cho（School of Pharmacy；Department of Clinical Oncology）.Exosome secretion from hypoxic cancer cells reshapes the tumor microenvironment and mediates drug resistance[J].癌症耐药(英文),2022,第3期
-
Amy H.Tang，Richard A.Hoefer，Mary L.Guye，Harry D.Bear（Department of Microbiology and Molecular Cell Biology；School of Systems Biology；Sentara Cancer Network；Sentara Surgery Specialists；Division of Surgical Oncology）.Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer[J].癌症耐药(英文),2022,第3期
-
Elise Vickridge，Camila C.F.Faraco，Alain Nepveu（Goodman Cancer Institute；Departments of Biochemistry；Medicine；Oncology）.Base excision repair accessory factors in senescence avoidance and resistance to treatments[J].癌症耐药(英文),2022,第3期
-
Cong He，Doulathunnisa Jaffar Ali，Bo Sun，Bei-Cheng Sun，Zhong-Dang Xiao（State Key Laboratory of Bioelectronics；Department of Hepatobiliary Surgery）.Microvesicles：the functional mediators in sorafenib resistance[J].癌症耐药(英文),2022,第3期
-
Jixian Xiong，Tiantian Zhang，Penglin Lan，Shuhong Zhang，Li Fu（Guangdong Provincial Key Laboratory of Regional Immunity and Diseases）.Insight into the molecular mechanisms of gastric cancer stem cell in drug resistance of gastric cancer[J].癌症耐药(英文),2022,第3期
-
Mario Cioce，Daniela Rutigliano，Annamaria Puglielli，Vito Michele Fazio（Department of Medicine；Institute of Translational Pharmacology）.Butein-instigated miR-186-5p-dependent modulation of TWIST1 affects resistance to cisplatin and bioenergetics of Malignant Pleural Mesothelioma cells[J].癌症耐药(英文),2022,第3期
-
James J.Ignatz-Hoover，James J.Driscoll（University Hospitals；Department of Biochemistry；Hematopoietic and Immune Cancer Biology Program）.Therapeutics to harness the immune microenvironment in multiple myeloma[J].癌症耐药(英文),2022,第3期
-
Dorian Yarih Garcia-Ortega，Sara Aileen Cabrera-Nieto，Haydee Sarai Caro-Sanchez，Marlid Cruz-Ramos（Cirugia Oncologica；Posgrado en Ciencias Medicas；Departamento de Patologi；Catedras de Consejo Nacional de Ciencia y Tecnologia（CONACYT））.An overview of resistance to chemotherapy in osteosarcoma and future perspectives[J].癌症耐药(英文),2022,第3期
-
Chunxia Su（Department of Oncology）.Emerging insights to lung cancer drug resistance[J].癌症耐药(英文),2022,第3期
-
Khoa Nguyen，Emily McConnell，Orielle Edwards，Bridgette M.Collins-Burow，Matthew E.Burow（Department of Medicine）.GD2+ cancer stem cells in triple-negative breast cancer：mechanisms of resistance to breast cancer therapies[J].癌症耐药(英文),2022,第3期
-
Katelyn E.Salotto，Walter C.Olson Jr，Karlyn E.Pollack，Anuradha Illendula，Elishama Michel，Sydney Henriques，Todd Fox，Susan Walker，Marya Dunlap-Brown，Craig L.Slingluff Jr，Mark Kester，Helena W.Snyde（w.snyder5；department of surgery；department of dermatology；department of pharmacology；university of virginia nanostar institute；molecular immunologic&translational sciences（mits）core；department of materials science）.A nano-enhanced vaccine for metastatic melanoma immunotherapy[J].癌症耐药(英文),2022,第3期
-
Luigi Sapio，Angela Ragone，Annamaria Spina，Alessia Salzillo，Silvio Naviglio（Department of Precision Medicine）.AdipoRon and Pancreatic Ductal Adenocarcinoma：a future perspective in overcoming chemotherapyinduced resistance?[J].癌症耐药(英文),2022,第3期
-
Rebekah Summey，Denise Uyar（Department of Obstetrics and Gynecology）.Ovarian cancer resistance to PARPi and platinumcontaining chemotherapy[J].癌症耐药(英文),2022,第3期
|